4d Pharma Share Discussion Threads

[dope007] 28/10/2020 09:43

Only Norwood knows why he is selling, what price he is prepared to accept, and how quickly he wants to be done by.

Stock price is currently suggesting a seller is still in the background

[trotterstrading] 28/10/2020 09:39

I don't think Norwood is looking to completely exit, if he was surely he would have sold around £1.80 in the run up to IBS results.I do think he would like to avoid flagging up on US regulatory/tax radars though, but I'm not sure what level he would need to sell down to for that to happen?

[master rsi] 28/10/2020 09:35

ozzy

Is your trade at the platform?
which one is it?

at the moment are bidding 111p the highest but the order book only gives 111.50p

[avsome1968] 28/10/2020 09:30

What price would you say is a good price?


If your a believer in DDDD and long term cant go wrong entering DDDD at this price.

[showmethemoneyhoney01] 28/10/2020 09:27

At least the volume is still high. Plenty of buying will soon allow D Norwood out assuming that is his intention. Chance for some cheap top ups especially considering the news flow from here on.

[ozzywalker] 28/10/2020 09:22

What price would you say is a good price?

[master rsi] 28/10/2020 09:17

re - ozzywalker
110p is my top up price but not been able to buy at it


I am sorry to say 110p is not a good price to go for at the time as they were and still are 3 MMs ahead of you, apart from others ( though I do not know your trade ) 2, 5 or 10K

the lowest "AT" were 110.50p and only about 3K were taken.

[avsome1968] 28/10/2020 09:01

Also would like to see a rns on Norwood going under 3%.

[avsome1968] 28/10/2020 08:56

Depends how bad the markets go, keeping bit of firepower in my wallet.

[ozzywalker] 28/10/2020 08:55

110p is my top up price but not been able to buy at it ..

[master rsi] 28/10/2020 08:50

The market has been sanguine this morning as almost everything was marked down till 8.40 am, and bit of a bounce of the FTSE just now.

Will the 110.50p will be the low of the day like yesterday?

------------------- FTSE------------------------------------ DDDD -------------

[1airbag] 28/10/2020 08:42

markets not looking good but in my mind 2 sectors will fair relatively well, biotech/pharma and mining shares (off the back of commodity prices).

[avsome1968] 28/10/2020 08:39

Airbag

Waiting for my top up, Markets not looking good

[1airbag] 28/10/2020 08:33

Added at 111.82p

[blueblood] 28/10/2020 08:21

In case anyone's missed it markets taking a bath this week. Will hold around these levels in run up to conference

[gooner1886] 28/10/2020 08:20

Merger price is 110p

[rastamouse] 28/10/2020 08:19

1 pound then any reversal Looking to add lower

[rastamouse] 28/10/2020 08:16

Lol..lol..

[avsome1968] 28/10/2020 08:13

Once David finished selling this will be back up.

[the stigologist] 28/10/2020 07:25

Astra Zeneca out with a RNS today boasting FDA have given them a Priority Review

"The Food and Drug Administration (FDA) grants Priority Review to applications for medicines that offer significant advances over available options by demonstrating safety or efficacy improvements, preventing serious conditions, or enhancing patient compliance. The Prescription Drug User Fee Act date, the FDA action date for their regulatory decision, will be during the first quarter of 2021."

Suspect 4D and Merck will be working on this in readiness for Phase II data on MRx0518 (although given serious unmet need maybe the Phase I SAFETY and EFFICACY will be enough to get them to jump the queue?)

[the stigologist] 28/10/2020 07:20

Even at this late stage in the whole covid story Big Pharma investing in early stage development of potential solutions from small bios

e.g. Novartis with a $200m+ headline deal ($50m upfront) with Molecular Partners today for drug candidates not even in Phase I yet !



"Multiple treatment options increases the likelihood of reaching and treating patients around the world and, in addition, may be especially important for certain populations at greater risk who may benefit from a prophylactic treatment."

[realist1950] 27/10/2020 23:51

I see a pretty busy news/update pipeline, all the way to mid/late January. And from there, who knows how things might have developed. All I do know is that with an enlarged OPEN trial running in a space that has already shown very promising results, you want exposure.....because the news can reveal itself at any time. And for that reason, as I've said, I'll remain in all the way through till late spring and, if the opportunity allows, add stock when I think it looks silly cheap.

An update on our >1B$ vaccines collaboration would be appreciated. Confidentiality clauses abound and since this deal was signed prior to Covid, it would certainly be interesting to learn if they have indeed since switched into this indication. (The deal was for up to three indications).

MERCK have kept a rather low profile with regards to the Covid vaccine space, which indeed was recently deemed newsworthy in itself.

An update in that direction would certainly put the cat amongst the pigeons, but even if they're busy on other indications, an update on this deal can only add value to what limited information is already in the public domain.

I think the BOD recognise the argument for disclosing more about this collaboration and feel it will come at some point.

Good luck and ADYOR.

All eyes on the conference.

[realist1950] 27/10/2020 23:38

Bermudashorts27 Oct '20 - 21:15 - 12857 of 12868
......................

A good spot there, Bermudashorts27. Marked up.